Micha Breakstone, PhD
CEO & Co-founder
Over 1 billion people worldwide suffer from neurological disorders, the leading cause of global disability.
We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
We are on the frontier of neurodegenerative diagnosis and treatment - working for a better tomorrow.